Drug Shortage Report for IRBESARTAN

Last updated on 2021-07-08 History
Report ID 108347
Drug Identification Number 02372347
Brand name IRBESARTAN
Common or Proper name IRBESARTAN
Company Name SANIS HEALTH INC
Market Status MARKETED
Active Ingredient(s) IRBESARTAN
Strength(s) 75MG
Dosage form(s) TABLET
Route of administration ORAL
Packaging size 100
ATC code C09CA
ATC description ANGIOTENSIN II ANTAGONISTS, PLAIN
Reason for shortage Disruption of the manufacture of the drug.
Anticipated start date 2020-11-30
Actual start date 2020-12-10
Estimated end date 2021-06-30
Actual end date 2021-07-07
Shortage status Resolved
Updated date 2021-07-08
Company comments
Health Canada comments
Tier 3 Status No
Contact Address 1 PRESIDENTS CHOICE CIRCLE
BRAMPTON, ONTARIO
CANADA L6Y 5S5
Company contact information

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v23 2021-07-08 English Compare
v22 2021-07-05 French Compare
v21 2021-07-05 English Compare
v20 2021-04-19 French Compare
v19 2021-04-19 English Compare
v18 2020-12-11 English Compare
v17 2020-12-10 French Compare
v16 2020-12-10 English Compare
v15 2020-12-10 French Compare
v14 2020-12-10 English Compare
v13 2020-12-10 English Compare
v12 2020-12-01 English Compare
v11 2020-10-20 French Compare
v10 2020-10-20 English Compare
v9 2020-10-20 English Compare
v8 2020-08-04 French Compare
v7 2020-08-04 English Compare
v6 2020-08-01 English Compare
v5 2020-07-08 French Compare
v4 2020-07-08 English Compare

Showing 1 to 20 of 23